Stocks and Investing Stocks and Investing
Tue, March 21, 2023
Mon, March 20, 2023
Sat, March 18, 2023
Fri, March 17, 2023
Thu, March 16, 2023

Serge Belanger Maintained (ARQT) at Strong Buy with Decreased Target to $24 on, Mar 16th, 2023


Published on 2024-10-28 02:17:37 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy with Decreased Target from $46 to $24 on, Mar 16th, 2023.

Serge has made no other calls on ARQT in the last 4 months.



There is 1 other peer that has a rating on ARQT. Out of the 1 peers that are also analyzing ARQT, 0 agree with Serge's Rating of Hold.



This is the rating of the analyst that currently disagrees with Serge


  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Decreased Target to $50 on, Wednesday, March 1st, 2023